285 related articles for article (PubMed ID: 24762250)
1. Vitamin K antagonist use for all patients with hypertrophic cardiomyopathy and atrial fibrillation: analysis of the literature and guideline review.
Oliphant CS; McCullough J; Hashim T; Khouzam RN
Future Cardiol; 2014 Mar; 10(2):229-33. PubMed ID: 24762250
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: A review.
Nasser MF; Gandhi S; Siegel RJ; Rader F
Heart Rhythm; 2021 Feb; 18(2):297-302. PubMed ID: 33022393
[TBL] [Abstract][Full Text] [Related]
3. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study.
Jung H; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Chest; 2019 Feb; 155(2):354-363. PubMed ID: 30472021
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic cardiomyopathy: a real risk factor for stroke.
Badawi RA; Seetharaman S; Birns J
Scott Med J; 2012 Feb; 57(1):60. PubMed ID: 22194403
[TBL] [Abstract][Full Text] [Related]
6. Stroke prevention in atrial fibrillation: do we still need warfarin?
Diener HC; Weber R; Lip GY; Hohnloser SH
Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?
Frontera A; Wilson DG; Sekhon H; Duncan ER; Thomas G
Clin Res Cardiol; 2015 Oct; 104(10):799-802. PubMed ID: 26133157
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonist (VKA) among patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis.
Rujirachun P; Charoenngam N; Wattanachayakul P; Winijkul A; Owattanapanich W; Ungprasert P
Acta Cardiol; 2020 Dec; 75(8):724-731. PubMed ID: 31558097
[No Abstract] [Full Text] [Related]
9. Antithrombotic treatment in atrial fibrillation.
Lip GY; Boos CJ
Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation.
Liew A; Eikelboom JW; O'Donnell M
Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171
[TBL] [Abstract][Full Text] [Related]
11. Stroke prevention in atrial fibrillation.
Freedman B; Potpara TS; Lip GY
Lancet; 2016 Aug; 388(10046):806-17. PubMed ID: 27560276
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
Paikin JS; Haroun MJ; Eikelboom JW
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):279-86. PubMed ID: 21438804
[TBL] [Abstract][Full Text] [Related]
13. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
Garcia DA
Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
[TBL] [Abstract][Full Text] [Related]
14. Prevention of stroke in patients with atrial fibrillation.
Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
[No Abstract] [Full Text] [Related]
15. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
16. Stroke prevention in atrial fibrillation: impact of novel oral anticoagulants.
Haft JI
Clin Appl Thromb Hemost; 2013 Jun; 19(3):241-8. PubMed ID: 22952215
[TBL] [Abstract][Full Text] [Related]
17. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
Chaudhari D; Bhuriya R; Arora R
Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986
[TBL] [Abstract][Full Text] [Related]
18. Preventing stroke in atrial fibrillation: the SPORTIF programme.
Lip GY
Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():25-30. PubMed ID: 15812201
[TBL] [Abstract][Full Text] [Related]
19. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
20. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
Schulman S
N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
